AbbVie Submits FDA Application for Etentamig in Relapsed or Refractory Multiple Myeloma

–  Etentamig is a second-generation BCMA-directed bispecific antibody T-cell engager with a clinical profile and dosing schedule that can pote...

October 29, 2026 | Thursday | News
Orphan Therapeutics Accelerator In-Licenses Gene Therapy for Rare Pediatric OTC Deficiency

OTXL-101, a promising therapy in development for a severe, rare pediatric metabolic condition, becomes the first pipeline program to be in-licensed by Or...

October 29, 2026 | Thursday | News
SEKISUI Diagnostics Launches 510(k)-Cleared COVID-19 and Flu A&B Combo Test

SEKISUI Diagnostics, a global medical diagnostics manufacturer, has announced the launch of a 510(k) cleared rapid test to detect COVID-19 and Flu A&...

October 29, 2026 | Thursday | News
CellsBin Wins NCI SBIR Award to Advance Blood-Based Multiple Myeloma Test

CellsBin®, a biotechnology company pioneering Rare-Cell Biology™, announced that it has received a Direct-to-Phase II Small Business Innov...

October 29, 2026 | Thursday | News
Abbott Launches Next-Generation Oncodetect MRD Test Using Whole-Genome Sequencing

Powered by whole-genome sequencing and MAESTRO* technology, the next-generation Oncodetect test takes a distinct approach to MRD,...

October 28, 2026 | Wednesday | News
GrOwnValve Achieves Primary Safety Endpoint in First Five Patients in Heart Valve Study

GrOwnValve GmbH, a Berlin-based medical technology company developing personalized heart valves from patients' own tissue, announced the achievement of t...

October 28, 2026 | Wednesday | News
Made Scientific Partners with CARR Biosystems to Scale Cell Therapy Manufacturing

Made Scientific to integrate multiple UniFuge® single-use centrifugation systems across its Princeton, NJ, and East Norriton, PA, facilities to suppo...

October 28, 2026 | Wednesday | News
Kos Biotechnology Partners Invests in Golden Age Health to Expand Rare Disease Drug Access in Asia

Golden Age Health is co-founded and chaired by Michel Vounatsos, former Biogen CEO and Merck President Kos Biotechnology Partners ("Kos"), a global ...

October 28, 2026 | Wednesday | News
Vetter Pharma Expands Fill-Finish Capacity to Meet Growing Demand for Injectable Medicines

As demand for injectable therapies grows and manufacturing requirements become more complex, Vetter Pharma is expanding its global fill-finish network to...

October 15, 2026 | Thursday | Interview
DaltonTx on Building a More Evidence-Led Approach to Antibody Discovery

Biopharma Boardroom speaks with Dr Anthony Bradley, Co-Founder and Chief Scientific Officer at DaltonTx, about how the company is b...

October 14, 2026 | Wednesday | Interview
Quotient Sciences and Acesion Pharma Collaborate on AI-Enhanced Formulation Development

  Quotient Sciences, a global integrated CRDMO (contract research, development and manufacturing organization), and Acesion Pharma, a Copenhagen-base...

September 30, 2026 | Wednesday | News
Vetter Expands Global Fill-and-Finish Network with Ten New Manufacturing Lines

  Strategic investments strengthen resilience and service capabilities for innovative injectable therapies First of ten additional commercial ma...

September 29, 2026 | Tuesday | News
NanoImaging Services and Proteos Launch TrueCourse Biosciences to Integrate Drug Discovery Capabilities

NanoImaging Services, a cryo-EM CRO, and Proteos, a protein production research partner, have  announced the launch of TrueCourse Biosciences, an in...

September 24, 2026 | Thursday | News
Bioiberica Highlights Heparin Research and Ingredient Security at CPHI Milan

Bioiberica, a global life science company, announces its return to CPHI Milan with a renewed mission to provide the high-quality, traceable and scientifi...

September 23, 2026 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2026 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close